Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.60984445 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.60984445 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.39627617 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.39627617 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.76438477 |
6 | lysine catabolic process (GO:0006554) | 5.68540579 |
7 | lysine metabolic process (GO:0006553) | 5.68540579 |
8 | glyoxylate metabolic process (GO:0046487) | 5.43406614 |
9 | cysteine metabolic process (GO:0006534) | 5.35246938 |
10 | sulfur amino acid catabolic process (GO:0000098) | 5.13612182 |
11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.10739957 |
12 | tryptophan catabolic process (GO:0006569) | 5.02358416 |
13 | indole-containing compound catabolic process (GO:0042436) | 5.02358416 |
14 | indolalkylamine catabolic process (GO:0046218) | 5.02358416 |
15 | kynurenine metabolic process (GO:0070189) | 4.98651209 |
16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90936099 |
17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.89531039 |
18 | bile acid biosynthetic process (GO:0006699) | 4.85278651 |
19 | tryptophan metabolic process (GO:0006568) | 4.73918883 |
20 | serine family amino acid catabolic process (GO:0009071) | 4.67664976 |
21 | amino-acid betaine metabolic process (GO:0006577) | 4.66182070 |
22 | homocysteine metabolic process (GO:0050667) | 4.57128874 |
23 | cellular ketone body metabolic process (GO:0046950) | 4.54211713 |
24 | * fatty acid beta-oxidation (GO:0006635) | 4.47288440 |
25 | acetyl-CoA metabolic process (GO:0006084) | 4.44352738 |
26 | valine metabolic process (GO:0006573) | 4.41918122 |
27 | urea metabolic process (GO:0019627) | 4.41395360 |
28 | urea cycle (GO:0000050) | 4.41395360 |
29 | regulation of triglyceride catabolic process (GO:0010896) | 4.36718158 |
30 | 2-oxoglutarate metabolic process (GO:0006103) | 4.34560227 |
31 | alpha-amino acid catabolic process (GO:1901606) | 4.30502413 |
32 | * short-chain fatty acid metabolic process (GO:0046459) | 4.30362444 |
33 | aspartate family amino acid catabolic process (GO:0009068) | 4.26379818 |
34 | L-serine metabolic process (GO:0006563) | 4.24938330 |
35 | * fatty acid oxidation (GO:0019395) | 4.23553289 |
36 | complement activation, alternative pathway (GO:0006957) | 4.21383064 |
37 | aromatic amino acid family metabolic process (GO:0009072) | 4.19259983 |
38 | drug transmembrane transport (GO:0006855) | 4.17375690 |
39 | bile acid metabolic process (GO:0008206) | 4.16851527 |
40 | * lipid oxidation (GO:0034440) | 4.15474160 |
41 | cellular amino acid catabolic process (GO:0009063) | 4.15231679 |
42 | * fatty acid catabolic process (GO:0009062) | 4.12591222 |
43 | nitrogen cycle metabolic process (GO:0071941) | 4.11485080 |
44 | branched-chain amino acid catabolic process (GO:0009083) | 4.09782898 |
45 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.06802797 |
46 | protein carboxylation (GO:0018214) | 4.06802797 |
47 | high-density lipoprotein particle remodeling (GO:0034375) | 4.01949986 |
48 | cellular modified amino acid catabolic process (GO:0042219) | 4.00893234 |
49 | branched-chain amino acid metabolic process (GO:0009081) | 3.99232900 |
50 | triglyceride homeostasis (GO:0070328) | 3.97627011 |
51 | acylglycerol homeostasis (GO:0055090) | 3.97627011 |
52 | tyrosine metabolic process (GO:0006570) | 3.96427873 |
53 | * monocarboxylic acid catabolic process (GO:0072329) | 3.95964319 |
54 | ethanol oxidation (GO:0006069) | 3.93735174 |
55 | glutamate metabolic process (GO:0006536) | 3.93577212 |
56 | coenzyme catabolic process (GO:0009109) | 3.93520701 |
57 | regulation of protein activation cascade (GO:2000257) | 3.93446864 |
58 | ketone body metabolic process (GO:1902224) | 3.92429124 |
59 | negative regulation of fibrinolysis (GO:0051918) | 3.89637245 |
60 | * carboxylic acid catabolic process (GO:0046395) | 3.87301542 |
61 | * organic acid catabolic process (GO:0016054) | 3.87301542 |
62 | fatty acid transmembrane transport (GO:1902001) | 3.84746460 |
63 | carnitine metabolic process (GO:0009437) | 3.83827914 |
64 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.82098225 |
65 | drug catabolic process (GO:0042737) | 3.80951647 |
66 | serine family amino acid metabolic process (GO:0009069) | 3.78821659 |
67 | urate metabolic process (GO:0046415) | 3.78491599 |
68 | regulation of fibrinolysis (GO:0051917) | 3.72320214 |
69 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.71276118 |
70 | regulation of complement activation (GO:0030449) | 3.70942657 |
71 | tricarboxylic acid metabolic process (GO:0072350) | 3.64213918 |
72 | carnitine shuttle (GO:0006853) | 3.63018575 |
73 | plasma lipoprotein particle clearance (GO:0034381) | 3.62372261 |
74 | tricarboxylic acid cycle (GO:0006099) | 3.58888364 |
75 | oxidative phosphorylation (GO:0006119) | 3.57846078 |
76 | regulation of mitochondrial translation (GO:0070129) | 3.56417900 |
77 | regulation of cholesterol homeostasis (GO:2000188) | 3.56308883 |
78 | positive regulation of lipid catabolic process (GO:0050996) | 3.55670062 |
79 | reverse cholesterol transport (GO:0043691) | 3.55497878 |
80 | indolalkylamine metabolic process (GO:0006586) | 3.54052050 |
81 | benzene-containing compound metabolic process (GO:0042537) | 3.51836959 |
82 | negative regulation of cholesterol transport (GO:0032375) | 3.51061144 |
83 | negative regulation of sterol transport (GO:0032372) | 3.51061144 |
84 | nucleobase biosynthetic process (GO:0046112) | 3.50959781 |
85 | protein-lipid complex remodeling (GO:0034368) | 3.49946162 |
86 | macromolecular complex remodeling (GO:0034367) | 3.49946162 |
87 | plasma lipoprotein particle remodeling (GO:0034369) | 3.49946162 |
88 | purine nucleobase biosynthetic process (GO:0009113) | 3.49639095 |
89 | * biotin metabolic process (GO:0006768) | 3.49571982 |
90 | cellular glucuronidation (GO:0052695) | 3.49417760 |
91 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.49171710 |
92 | glycine metabolic process (GO:0006544) | 3.47495846 |
93 | bile acid and bile salt transport (GO:0015721) | 3.47189788 |
94 | regulation of cholesterol esterification (GO:0010872) | 3.44181593 |
95 | positive regulation of fatty acid oxidation (GO:0046321) | 3.43909357 |
96 | drug transport (GO:0015893) | 3.40290375 |
97 | regulation of sequestering of triglyceride (GO:0010889) | 3.35191390 |
98 | phospholipid homeostasis (GO:0055091) | 3.34743841 |
99 | response to mercury ion (GO:0046689) | 3.34331883 |
100 | exogenous drug catabolic process (GO:0042738) | 3.33534549 |
101 | amine catabolic process (GO:0009310) | 3.33309185 |
102 | cellular biogenic amine catabolic process (GO:0042402) | 3.33309185 |
103 | serine family amino acid biosynthetic process (GO:0009070) | 3.33151412 |
104 | regulation of cholesterol metabolic process (GO:0090181) | 3.31278968 |
105 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.28465213 |
106 | * small molecule catabolic process (GO:0044282) | 3.25249642 |
107 | drug metabolic process (GO:0017144) | 3.24086923 |
108 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.18494735 |
109 | tetrahydrofolate metabolic process (GO:0046653) | 3.07095860 |
110 | DNA strand elongation (GO:0022616) | 3.04132318 |
111 | proteasome assembly (GO:0043248) | 3.02128855 |
112 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.00162490 |
113 | regulation of translational fidelity (GO:0006450) | 2.96532384 |
114 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.96366391 |
115 | ATP synthesis coupled proton transport (GO:0015986) | 2.96366391 |
116 | L-methionine salvage (GO:0071267) | 2.94518772 |
117 | L-methionine biosynthetic process (GO:0071265) | 2.94518772 |
118 | amino acid salvage (GO:0043102) | 2.94518772 |
119 | oxaloacetate metabolic process (GO:0006107) | 2.91504419 |
120 | tRNA aminoacylation for protein translation (GO:0006418) | 2.90303812 |
121 | ribosome assembly (GO:0042255) | 2.88782631 |
122 | IMP biosynthetic process (GO:0006188) | 2.88384151 |
123 | mitochondrial RNA metabolic process (GO:0000959) | 2.87641235 |
124 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.86985074 |
125 | sulfur amino acid biosynthetic process (GO:0000097) | 2.86801644 |
126 | amino acid activation (GO:0043038) | 2.85728427 |
127 | tRNA aminoacylation (GO:0043039) | 2.85728427 |
128 | establishment of integrated proviral latency (GO:0075713) | 2.85567690 |
129 | aldehyde catabolic process (GO:0046185) | 2.83162574 |
130 | DNA replication checkpoint (GO:0000076) | 2.81148265 |
131 | formation of translation preinitiation complex (GO:0001731) | 2.78300783 |
132 | rRNA modification (GO:0000154) | 2.78272430 |
133 | CENP-A containing nucleosome assembly (GO:0034080) | 2.78266656 |
134 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.77927530 |
135 | chromatin remodeling at centromere (GO:0031055) | 2.73264049 |
136 | NADH metabolic process (GO:0006734) | 2.72448833 |
137 | cullin deneddylation (GO:0010388) | 2.69610836 |
138 | folic acid-containing compound metabolic process (GO:0006760) | 2.68629430 |
139 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.66848423 |
140 | ubiquinone biosynthetic process (GO:0006744) | 2.64179378 |
141 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.63005917 |
142 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.62726329 |
143 | proline biosynthetic process (GO:0006561) | 2.62236137 |
144 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.61477604 |
145 | ubiquinone metabolic process (GO:0006743) | 2.61257721 |
146 | methionine biosynthetic process (GO:0009086) | 2.61078107 |
147 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.60304553 |
148 | respiratory electron transport chain (GO:0022904) | 2.59363047 |
149 | DNA unwinding involved in DNA replication (GO:0006268) | 2.59131187 |
150 | DNA ligation (GO:0006266) | 2.58723795 |
151 | DNA replication initiation (GO:0006270) | 2.57805311 |
152 | pseudouridine synthesis (GO:0001522) | 2.57290368 |
153 | respiratory chain complex IV assembly (GO:0008535) | 2.55676355 |
154 | methionine metabolic process (GO:0006555) | 2.55446128 |
155 | electron transport chain (GO:0022900) | 2.54744528 |
156 | IMP metabolic process (GO:0046040) | 2.54672270 |
157 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.54134041 |
158 | pteridine-containing compound metabolic process (GO:0042558) | 2.53771252 |
159 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.53185872 |
160 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.53185872 |
161 | telomere maintenance via recombination (GO:0000722) | 2.52817679 |
162 | aerobic respiration (GO:0009060) | 2.52641811 |
163 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.52608742 |
164 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.52492621 |
165 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.51952687 |
166 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.50658979 |
167 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.50658979 |
168 | ribosome biogenesis (GO:0042254) | 2.50478226 |
169 | aspartate family amino acid metabolic process (GO:0009066) | 2.48767443 |
170 | alpha-amino acid biosynthetic process (GO:1901607) | 2.48214726 |
171 | mitotic recombination (GO:0006312) | 2.46498006 |
172 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.46428114 |
173 | transcription from mitochondrial promoter (GO:0006390) | 2.45807000 |
174 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.42981403 |
175 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.41979493 |
176 | cholesterol biosynthetic process (GO:0006695) | 2.39463568 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.26562069 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.92878734 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.26434212 |
4 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.24901141 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.72273308 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.91981799 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.55560850 |
8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.54097692 |
9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.89538826 |
10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.86504301 |
11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.76361228 |
12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.69262603 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.24514812 |
14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.24479797 |
15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.21278397 |
16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.09901684 |
17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.06930381 |
18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.02671343 |
19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.02184987 |
20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.96457433 |
21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.91015378 |
22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.81306404 |
23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.80283570 |
24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.72319708 |
25 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.58136208 |
26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.52489309 |
27 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.52378013 |
28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.33148983 |
29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.29977113 |
30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.28455609 |
31 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.27645885 |
32 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.27581379 |
33 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.26534422 |
34 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.23339391 |
35 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.20953159 |
36 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.19290172 |
37 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09310577 |
38 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.04444704 |
39 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.04037817 |
40 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.03484258 |
41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01289535 |
42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0360434 |
43 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99463836 |
44 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.96536962 |
45 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.95534054 |
46 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94319432 |
47 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.90510065 |
48 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.87915874 |
49 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.87783710 |
50 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.87528350 |
51 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.85753229 |
52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.85644140 |
53 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.84547909 |
54 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.82551232 |
55 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.81312301 |
56 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.76851227 |
57 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.74703171 |
58 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.71739239 |
59 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.69844896 |
60 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.68875199 |
61 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65334649 |
62 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.62154678 |
63 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59884227 |
64 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.59323895 |
65 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55572291 |
66 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.48316342 |
67 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.46296723 |
68 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.44811221 |
69 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.44247970 |
70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.43728352 |
71 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38688772 |
72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38601357 |
73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.37606454 |
74 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34408891 |
75 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33948720 |
76 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28515655 |
77 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.25722432 |
78 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24856574 |
79 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24544077 |
80 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20744780 |
81 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.19931273 |
82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.10867806 |
83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10654223 |
84 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10641091 |
85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10260942 |
86 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.06761243 |
87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04999725 |
88 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.04822751 |
89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04780641 |
90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04468520 |
91 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.03528954 |
92 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03095353 |
93 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.03063735 |
94 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00751184 |
95 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99066419 |
96 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.98303521 |
97 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97207009 |
98 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96969822 |
99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96903291 |
100 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96361212 |
101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96211717 |
102 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95799202 |
103 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93789224 |
104 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91501632 |
105 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.91173222 |
106 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.91173222 |
107 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90763246 |
108 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.89823525 |
109 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.89411218 |
110 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.89310003 |
111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89187797 |
112 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88799361 |
113 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.87622733 |
114 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.87337798 |
115 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.86798785 |
116 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86431318 |
117 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.86051803 |
118 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.85556407 |
119 | * IGF1R_20145208_ChIP-Seq_DFB_Human | 0.85225845 |
120 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.84553912 |
121 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.83875503 |
122 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83862246 |
123 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82039029 |
124 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.81404378 |
125 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.80176688 |
126 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80114408 |
127 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79119453 |
128 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77106852 |
129 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.77008870 |
130 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76655847 |
131 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76545284 |
132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76341409 |
133 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74595799 |
134 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74595799 |
135 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.74574023 |
136 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.74030977 |
137 | EWS_26573619_Chip-Seq_HEK293_Human | 0.73733656 |
138 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.73396601 |
139 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69845130 |
140 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.69110660 |
141 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68750683 |
142 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.68721178 |
143 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.67974853 |
144 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.67385555 |
145 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67362186 |
146 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.66474616 |
147 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.66214498 |
148 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.66123404 |
149 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65994218 |
150 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65789446 |
151 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65646541 |
152 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.64810646 |
153 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63672753 |
154 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.63549742 |
155 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.62252066 |
156 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61644185 |
157 | GATA1_19941826_ChIP-Seq_K562_Human | 0.61595863 |
158 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.61048846 |
159 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.60617413 |
160 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60050797 |
161 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.59869669 |
162 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.58148206 |
163 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57747228 |
164 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.57171263 |
165 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.56752996 |
166 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.56568424 |
167 | GATA2_19941826_ChIP-Seq_K562_Human | 0.56192077 |
168 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55943585 |
169 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55111487 |
170 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.53941337 |
171 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.52921051 |
172 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.52727325 |
173 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.52181142 |
174 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52174767 |
175 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51988800 |
176 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50417838 |
177 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.50009529 |
178 | AR_20517297_ChIP-Seq_VCAP_Human | 0.48134357 |
179 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.48102963 |
180 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48070638 |
181 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.47449800 |
182 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47130131 |
183 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.47118776 |
184 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46639445 |
185 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.46030032 |
186 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.45016102 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.24371431 |
2 | MP0005360_urolithiasis | 6.90481986 |
3 | MP0005365_abnormal_bile_salt | 5.46685620 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.44339146 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.32560640 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.53091429 |
7 | MP0003252_abnormal_bile_duct | 3.47378213 |
8 | MP0010329_abnormal_lipoprotein_level | 3.31005324 |
9 | MP0005332_abnormal_amino_acid | 3.19641733 |
10 | MP0010094_abnormal_chromosome_stability | 3.09751404 |
11 | MP0003195_calcinosis | 3.03055552 |
12 | MP0008058_abnormal_DNA_repair | 2.99593063 |
13 | MP0003718_maternal_effect | 2.71861551 |
14 | MP0003693_abnormal_embryo_hatching | 2.69420256 |
15 | MP0004957_abnormal_blastocyst_morpholog | 2.67310797 |
16 | MP0001666_abnormal_nutrient_absorption | 2.60294053 |
17 | MP0005083_abnormal_biliary_tract | 2.56371364 |
18 | MP0009840_abnormal_foam_cell | 2.53244292 |
19 | MP0003111_abnormal_nucleus_morphology | 2.49919223 |
20 | MP0004147_increased_porphyrin_level | 2.39809648 |
21 | MP0004019_abnormal_vitamin_homeostasis | 2.36080528 |
22 | MP0002118_abnormal_lipid_homeostasis | 2.25583041 |
23 | MP0005670_abnormal_white_adipose | 2.17411404 |
24 | MP0003077_abnormal_cell_cycle | 2.14886134 |
25 | MP0003191_abnormal_cellular_cholesterol | 2.14501295 |
26 | MP0008877_abnormal_DNA_methylation | 2.04508455 |
27 | MP0002837_dystrophic_cardiac_calcinosis | 1.99575025 |
28 | MP0000609_abnormal_liver_physiology | 1.96054517 |
29 | MP0008057_abnormal_DNA_replication | 1.91103389 |
30 | MP0008932_abnormal_embryonic_tissue | 1.90726993 |
31 | MP0002138_abnormal_hepatobiliary_system | 1.90640005 |
32 | MP0004130_abnormal_muscle_cell | 1.90025335 |
33 | MP0004043_abnormal_pH_regulation | 1.87924144 |
34 | MP0009643_abnormal_urine_homeostasis | 1.85901944 |
35 | MP0005319_abnormal_enzyme/_coenzyme | 1.83507361 |
36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.71319714 |
37 | MP0003941_abnormal_skin_development | 1.70367936 |
38 | MP0005666_abnormal_adipose_tissue | 1.64940572 |
39 | MP0008995_early_reproductive_senescence | 1.62215375 |
40 | MP0006036_abnormal_mitochondrial_physio | 1.52722478 |
41 | MP0003868_abnormal_feces_composition | 1.52362237 |
42 | MP0008007_abnormal_cellular_replicative | 1.50903385 |
43 | MP0001764_abnormal_homeostasis | 1.48732932 |
44 | MP0003786_premature_aging | 1.46160368 |
45 | MP0001529_abnormal_vocalization | 1.42056916 |
46 | MP0004145_abnormal_muscle_electrophysio | 1.41991404 |
47 | MP0003123_paternal_imprinting | 1.37687309 |
48 | MP0003705_abnormal_hypodermis_morpholog | 1.36445381 |
49 | MP0003186_abnormal_redox_activity | 1.35719100 |
50 | MP0002938_white_spotting | 1.34519537 |
51 | MP0001756_abnormal_urination | 1.30351374 |
52 | MP0005451_abnormal_body_composition | 1.29971982 |
53 | MP0002971_abnormal_brown_adipose | 1.29761521 |
54 | MP0004233_abnormal_muscle_weight | 1.29546584 |
55 | MP0005636_abnormal_mineral_homeostasis | 1.27495363 |
56 | MP0000372_irregular_coat_pigmentation | 1.25194328 |
57 | MP0001730_embryonic_growth_arrest | 1.24909412 |
58 | MP0005535_abnormal_body_temperature | 1.24067683 |
59 | MP0001929_abnormal_gametogenesis | 1.23477351 |
60 | MP0009672_abnormal_birth_weight | 1.18658924 |
61 | MP0002090_abnormal_vision | 1.17081275 |
62 | MP0006292_abnormal_olfactory_placode | 1.15894134 |
63 | MP0002078_abnormal_glucose_homeostasis | 1.15446265 |
64 | MP0008789_abnormal_olfactory_epithelium | 1.11785110 |
65 | MP0000358_abnormal_cell_content/ | 1.10239681 |
66 | MP0004185_abnormal_adipocyte_glucose | 1.07753446 |
67 | MP0005410_abnormal_fertilization | 1.06898213 |
68 | MP0002876_abnormal_thyroid_physiology | 1.05581755 |
69 | MP0003136_yellow_coat_color | 1.04509795 |
70 | MP0003646_muscle_fatigue | 1.03695769 |
71 | MP0001727_abnormal_embryo_implantation | 1.03203699 |
72 | MP0005334_abnormal_fat_pad | 1.02880259 |
73 | MP0005379_endocrine/exocrine_gland_phen | 1.02522437 |
74 | MP0005375_adipose_tissue_phenotype | 1.02182431 |
75 | MP0002210_abnormal_sex_determination | 1.02038550 |
76 | MP0002160_abnormal_reproductive_system | 1.01416031 |
77 | MP0001672_abnormal_embryogenesis/_devel | 1.00586902 |
78 | MP0005380_embryogenesis_phenotype | 1.00586902 |
79 | MP0001293_anophthalmia | 1.00466840 |
80 | MP0001697_abnormal_embryo_size | 1.00201629 |
81 | MP0000598_abnormal_liver_morphology | 0.98511925 |
82 | MP0003567_abnormal_fetal_cardiomyocyte | 0.97821549 |
83 | MP0002234_abnormal_pharynx_morphology | 0.95731920 |
84 | MP0000653_abnormal_sex_gland | 0.95200674 |
85 | MP0001145_abnormal_male_reproductive | 0.94078522 |
86 | MP0001661_extended_life_span | 0.93256602 |
87 | MP0001765_abnormal_ion_homeostasis | 0.92911978 |
88 | MP0003698_abnormal_male_reproductive | 0.91717682 |
89 | MP0006072_abnormal_retinal_apoptosis | 0.91494349 |
90 | MP0003656_abnormal_erythrocyte_physiolo | 0.90393442 |
91 | MP0000749_muscle_degeneration | 0.90087252 |
92 | MP0003984_embryonic_growth_retardation | 0.89810656 |
93 | MP0002088_abnormal_embryonic_growth/wei | 0.88609897 |
94 | MP0005647_abnormal_sex_gland | 0.88404204 |
95 | MP0005084_abnormal_gallbladder_morpholo | 0.87880277 |
96 | MP0009642_abnormal_blood_homeostasis | 0.86528017 |
97 | MP0003011_delayed_dark_adaptation | 0.85826056 |
98 | MP0005394_taste/olfaction_phenotype | 0.85754764 |
99 | MP0005499_abnormal_olfactory_system | 0.85754764 |
100 | MP0005187_abnormal_penis_morphology | 0.85750058 |
101 | MP0005395_other_phenotype | 0.85581720 |
102 | MP0002080_prenatal_lethality | 0.85343760 |
103 | MP0005330_cardiomyopathy | 0.83644255 |
104 | MP0005645_abnormal_hypothalamus_physiol | 0.83246070 |
105 | MP0002136_abnormal_kidney_physiology | 0.82490349 |
106 | MP0005220_abnormal_exocrine_pancreas | 0.82164110 |
107 | MP0001984_abnormal_olfaction | 0.81914223 |
108 | MP0005253_abnormal_eye_physiology | 0.81900747 |
109 | MP0000604_amyloidosis | 0.81317079 |
110 | MP0005448_abnormal_energy_balance | 0.78984321 |
111 | MP0000350_abnormal_cell_proliferation | 0.78720351 |
112 | MP0003121_genomic_imprinting | 0.78654444 |
113 | MP0002084_abnormal_developmental_patter | 0.77663053 |
114 | MP0000230_abnormal_systemic_arterial | 0.77621603 |
115 | MP0006035_abnormal_mitochondrial_morpho | 0.77449648 |
116 | MP0003315_abnormal_perineum_morphology | 0.76942900 |
117 | MP0010234_abnormal_vibrissa_follicle | 0.76586201 |
118 | MP0003329_amyloid_beta_deposits | 0.74652627 |
119 | MP0002163_abnormal_gland_morphology | 0.72297748 |
120 | MP0003690_abnormal_glial_cell | 0.72182650 |
121 | MP0010368_abnormal_lymphatic_system | 0.71809062 |
122 | MP0000313_abnormal_cell_death | 0.70938223 |
123 | MP0005551_abnormal_eye_electrophysiolog | 0.70613202 |
124 | MP0002161_abnormal_fertility/fecundity | 0.70316399 |
125 | MP0009115_abnormal_fat_cell | 0.69959045 |
126 | MP0005058_abnormal_lysosome_morphology | 0.69589072 |
127 | MP0009697_abnormal_copulation | 0.69284886 |
128 | MP0002085_abnormal_embryonic_tissue | 0.69253663 |
129 | MP0005376_homeostasis/metabolism_phenot | 0.68921445 |
130 | MP0009764_decreased_sensitivity_to | 0.68413713 |
131 | MP0005266_abnormal_metabolism | 0.67875979 |
132 | MP0003953_abnormal_hormone_level | 0.67452597 |
133 | MP0009763_increased_sensitivity_to | 0.65909690 |
134 | MP0004036_abnormal_muscle_relaxation | 0.64604678 |
135 | MP0003959_abnormal_lean_body | 0.64542270 |
136 | MP0008961_abnormal_basal_metabolism | 0.63568646 |
137 | MP0002970_abnormal_white_adipose | 0.61986930 |
138 | MP0002269_muscular_atrophy | 0.61131914 |
139 | MP0008469_abnormal_protein_level | 0.59918309 |
140 | MP0002254_reproductive_system_inflammat | 0.59230610 |
141 | MP0009780_abnormal_chondrocyte_physiolo | 0.57658242 |
142 | MP0000003_abnormal_adipose_tissue | 0.54541005 |
143 | MP0000751_myopathy | 0.53927834 |
144 | MP0000013_abnormal_adipose_tissue | 0.53790366 |
145 | MP0005408_hypopigmentation | 0.53291404 |
146 | MP0000747_muscle_weakness | 0.53080820 |
147 | MP0002822_catalepsy | 0.51457980 |
148 | MP0006138_congestive_heart_failure | 0.50604259 |
149 | MP0004087_abnormal_muscle_fiber | 0.50040415 |
150 | MP0002168_other_aberrant_phenotype | 0.48123366 |
151 | MP0002796_impaired_skin_barrier | 0.47969960 |
152 | MP0009765_abnormal_xenobiotic_induced | 0.47316745 |
153 | MP0005620_abnormal_muscle_contractility | 0.47157405 |
154 | MP0004215_abnormal_myocardial_fiber | 0.46720515 |
155 | MP0001944_abnormal_pancreas_morphology | 0.46669715 |
156 | MP0003638_abnormal_response/metabolism_ | 0.45733459 |
157 | MP0005385_cardiovascular_system_phenoty | 0.44950418 |
158 | MP0001544_abnormal_cardiovascular_syste | 0.44950418 |
159 | MP0005452_abnormal_adipose_tissue | 0.44392412 |
160 | MP0008775_abnormal_heart_ventricle | 0.43448890 |
161 | MP0002972_abnormal_cardiac_muscle | 0.43319513 |
162 | MP0000538_abnormal_urinary_bladder | 0.42810871 |
163 | MP0002928_abnormal_bile_duct | 0.42563723 |
164 | MP0003221_abnormal_cardiomyocyte_apopto | 0.42168991 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.91872306 |
2 | Intrahepatic cholestasis (HP:0001406) | 5.59291493 |
3 | Deep venous thrombosis (HP:0002625) | 5.23365009 |
4 | Xanthomatosis (HP:0000991) | 5.13946234 |
5 | * Hyperglycinuria (HP:0003108) | 5.04843998 |
6 | Ketosis (HP:0001946) | 4.97376898 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.85834092 |
8 | * Abnormality of serine family amino acid metabolism (HP:0010894) | 4.64648250 |
9 | * Abnormality of glycine metabolism (HP:0010895) | 4.64648250 |
10 | Hypoglycemic coma (HP:0001325) | 4.63339643 |
11 | * Hyperammonemia (HP:0001987) | 4.59744855 |
12 | Ketoacidosis (HP:0001993) | 4.57594310 |
13 | Hyperlipoproteinemia (HP:0010980) | 4.41136550 |
14 | Abnormality of glycolysis (HP:0004366) | 4.39626505 |
15 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.36584174 |
16 | Increased serum pyruvate (HP:0003542) | 4.26535874 |
17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.25749849 |
18 | Hypobetalipoproteinemia (HP:0003563) | 4.24133413 |
19 | Prolonged partial thromboplastin time (HP:0003645) | 4.16457092 |
20 | Complement deficiency (HP:0004431) | 4.08664676 |
21 | * Hyperglycinemia (HP:0002154) | 4.07093681 |
22 | Gout (HP:0001997) | 3.88639424 |
23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.60728487 |
24 | Dicarboxylic aciduria (HP:0003215) | 3.60604145 |
25 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.60604145 |
26 | * Acute encephalopathy (HP:0006846) | 3.59251399 |
27 | Hypolipoproteinemia (HP:0010981) | 3.59085125 |
28 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.56787438 |
29 | Epidermoid cyst (HP:0200040) | 3.54555959 |
30 | Hypoalphalipoproteinemia (HP:0003233) | 3.51008443 |
31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.50502237 |
32 | Acute necrotizing encephalopathy (HP:0006965) | 3.44929857 |
33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.38425453 |
34 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.35750998 |
35 | Abnormality of purine metabolism (HP:0004352) | 3.33920024 |
36 | Generalized aminoaciduria (HP:0002909) | 3.25016413 |
37 | Fat malabsorption (HP:0002630) | 3.16643420 |
38 | Abnormality of the common coagulation pathway (HP:0010990) | 3.08034356 |
39 | Microvesicular hepatic steatosis (HP:0001414) | 3.02557259 |
40 | Delayed CNS myelination (HP:0002188) | 3.01913306 |
41 | * Metabolic acidosis (HP:0001942) | 3.00937924 |
42 | Increased CSF lactate (HP:0002490) | 2.99307475 |
43 | Joint hemorrhage (HP:0005261) | 2.97554903 |
44 | Abnormality of methionine metabolism (HP:0010901) | 2.97250543 |
45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.96928536 |
46 | * Lethargy (HP:0001254) | 2.92047488 |
47 | Proximal tubulopathy (HP:0000114) | 2.87792491 |
48 | Abnormality of the anterior horn cell (HP:0006802) | 2.85492334 |
49 | Degeneration of anterior horn cells (HP:0002398) | 2.85492334 |
50 | Mitochondrial inheritance (HP:0001427) | 2.84694822 |
51 | Myoglobinuria (HP:0002913) | 2.84602739 |
52 | Hyperuricemia (HP:0002149) | 2.84348096 |
53 | Increased purine levels (HP:0004368) | 2.84348096 |
54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.84126354 |
55 | Progressive macrocephaly (HP:0004481) | 2.81979576 |
56 | * Abnormality of serum amino acid levels (HP:0003112) | 2.80025838 |
57 | Abnormality of alanine metabolism (HP:0010916) | 2.78533372 |
58 | Hyperalaninemia (HP:0003348) | 2.78533372 |
59 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.78533372 |
60 | Abnormality of complement system (HP:0005339) | 2.78325812 |
61 | Increased serum lactate (HP:0002151) | 2.77050502 |
62 | Cerebral edema (HP:0002181) | 2.75673333 |
63 | Conjugated hyperbilirubinemia (HP:0002908) | 2.75247672 |
64 | Hepatocellular necrosis (HP:0001404) | 2.71473837 |
65 | Lipid accumulation in hepatocytes (HP:0006561) | 2.70660961 |
66 | Hypoglycemic seizures (HP:0002173) | 2.70341909 |
67 | Hyperbilirubinemia (HP:0002904) | 2.69646260 |
68 | * Lactic acidosis (HP:0003128) | 2.67478827 |
69 | Hypercholesterolemia (HP:0003124) | 2.67144598 |
70 | Hydroxyprolinuria (HP:0003080) | 2.62570731 |
71 | Abnormality of proline metabolism (HP:0010907) | 2.62570731 |
72 | * Vomiting (HP:0002013) | 2.52888846 |
73 | Skin nodule (HP:0200036) | 2.50494138 |
74 | Increased hepatocellular lipid droplets (HP:0006565) | 2.50363838 |
75 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.49355263 |
76 | Alkalosis (HP:0001948) | 2.46777445 |
77 | Hepatocellular carcinoma (HP:0001402) | 2.42603832 |
78 | Late onset (HP:0003584) | 2.41424030 |
79 | Multiple enchondromatosis (HP:0005701) | 2.41031343 |
80 | Chromsome breakage (HP:0040012) | 2.39726891 |
81 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.39321168 |
82 | Vascular calcification (HP:0004934) | 2.38396782 |
83 | Glycosuria (HP:0003076) | 2.38208144 |
84 | Abnormality of urine glucose concentration (HP:0011016) | 2.38208144 |
85 | Type I transferrin isoform profile (HP:0003642) | 2.36862340 |
86 | Neoplasm of the adrenal gland (HP:0100631) | 2.34494581 |
87 | Birth length less than 3rd percentile (HP:0003561) | 2.33302779 |
88 | Steatorrhea (HP:0002570) | 2.32860504 |
89 | Reduced antithrombin III activity (HP:0001976) | 2.30622856 |
90 | Irritability (HP:0000737) | 2.28928367 |
91 | Malnutrition (HP:0004395) | 2.24383931 |
92 | Abnormality of the labia minora (HP:0012880) | 2.23411934 |
93 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.22945562 |
94 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.19926688 |
95 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.19926688 |
96 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.19736173 |
97 | Neonatal onset (HP:0003623) | 2.19627065 |
98 | Abnormal number of erythroid precursors (HP:0012131) | 2.18889114 |
99 | Sensorimotor neuropathy (HP:0007141) | 2.18021215 |
100 | Exercise intolerance (HP:0003546) | 2.17872906 |
101 | Abnormal gallbladder morphology (HP:0012437) | 2.15741624 |
102 | Increased intramyocellular lipid droplets (HP:0012240) | 2.15421790 |
103 | Cardiovascular calcification (HP:0011915) | 2.14347770 |
104 | Myocardial infarction (HP:0001658) | 2.13951782 |
105 | Cholelithiasis (HP:0001081) | 2.13242140 |
106 | Enlarged kidneys (HP:0000105) | 2.13061510 |
107 | Abnormal cartilage morphology (HP:0002763) | 2.11899624 |
108 | Hyperglycemia (HP:0003074) | 2.11705495 |
109 | Respiratory failure (HP:0002878) | 2.10784563 |
110 | Rhabdomyolysis (HP:0003201) | 2.08659870 |
111 | Progressive muscle weakness (HP:0003323) | 2.08452345 |
112 | 3-Methylglutaconic aciduria (HP:0003535) | 2.07487154 |
113 | Hepatic necrosis (HP:0002605) | 2.06935655 |
114 | * Pancreatitis (HP:0001733) | 2.06355303 |
115 | Spastic diplegia (HP:0001264) | 2.06264219 |
116 | Increased muscle lipid content (HP:0009058) | 2.05806667 |
117 | Methylmalonic aciduria (HP:0012120) | 2.03967866 |
118 | Nausea (HP:0002018) | 2.02087282 |
119 | CNS demyelination (HP:0007305) | 2.00785253 |
120 | Ragged-red muscle fibers (HP:0003200) | 1.99324633 |
121 | Methylmalonic acidemia (HP:0002912) | 1.99239185 |
122 | Abnormal protein glycosylation (HP:0012346) | 1.98171678 |
123 | Abnormal glycosylation (HP:0012345) | 1.98171678 |
124 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.98171678 |
125 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.98171678 |
126 | Hypokalemic alkalosis (HP:0001949) | 1.97959457 |
127 | Testicular atrophy (HP:0000029) | 1.97756140 |
128 | Renal Fanconi syndrome (HP:0001994) | 1.97476724 |
129 | Brushfield spots (HP:0001088) | 1.95524457 |
130 | Exercise-induced muscle cramps (HP:0003710) | 1.94785161 |
131 | Hyperactive renin-angiotensin system (HP:0000841) | 1.92930433 |
132 | Systemic lupus erythematosus (HP:0002725) | 1.92091132 |
133 | Cholecystitis (HP:0001082) | 1.91906020 |
134 | Abnormal gallbladder physiology (HP:0012438) | 1.91906020 |
135 | Renal cortical cysts (HP:0000803) | 1.90227765 |
136 | Symptomatic seizures (HP:0011145) | 1.89509321 |
137 | Colon cancer (HP:0003003) | 1.88302222 |
138 | Reticulocytopenia (HP:0001896) | 1.87938014 |
139 | Increased circulating renin level (HP:0000848) | 1.86863008 |
140 | Cerebral palsy (HP:0100021) | 1.86698248 |
141 | Rickets (HP:0002748) | 1.83717978 |
142 | Abnormality of reticulocytes (HP:0004312) | 1.83179233 |
143 | Nephrolithiasis (HP:0000787) | 1.82026326 |
144 | Reticulocytosis (HP:0001923) | 1.80925073 |
145 | Meckel diverticulum (HP:0002245) | 1.79475322 |
146 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79352218 |
147 | Exercise-induced myalgia (HP:0003738) | 1.78776944 |
148 | Spontaneous abortion (HP:0005268) | 1.76972312 |
149 | Metabolic alkalosis (HP:0200114) | 1.76075979 |
150 | Hypertriglyceridemia (HP:0002155) | 1.75710374 |
151 | Abnormality of the gallbladder (HP:0005264) | 1.73748675 |
152 | Abnormality of vitamin metabolism (HP:0100508) | 1.72620141 |
153 | Abnormality of the ileum (HP:0001549) | 1.67614712 |
154 | Leukodystrophy (HP:0002415) | 1.66139225 |
155 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.64631567 |
156 | Secondary amenorrhea (HP:0000869) | 1.63521120 |
157 | Abnormal lung lobation (HP:0002101) | 1.62451727 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.62759884 |
2 | BUB1 | 3.59138584 |
3 | SIK1 | 3.37652515 |
4 | VRK2 | 3.35496290 |
5 | TRIB3 | 3.29581738 |
6 | EIF2AK1 | 3.25455694 |
7 | PBK | 3.02316985 |
8 | INSRR | 2.91014175 |
9 | WNK4 | 2.87826792 |
10 | CDC7 | 2.87478800 |
11 | ERN1 | 2.85973840 |
12 | TTK | 2.82337986 |
13 | TAOK3 | 2.67224457 |
14 | FGFR4 | 2.60709424 |
15 | PDK3 | 2.57480748 |
16 | PDK4 | 2.57480748 |
17 | EIF2AK3 | 2.49274754 |
18 | SRPK1 | 2.29617094 |
19 | TSSK6 | 2.18923997 |
20 | WNK3 | 2.17781622 |
21 | ZAK | 2.15695798 |
22 | PKN2 | 2.13267914 |
23 | MST1R | 2.00204082 |
24 | VRK1 | 1.96700761 |
25 | PDK2 | 1.90032490 |
26 | OXSR1 | 1.89516690 |
27 | MST4 | 1.78251817 |
28 | WEE1 | 1.77166400 |
29 | PLK4 | 1.76275033 |
30 | PLK3 | 1.72917184 |
31 | SCYL2 | 1.69275682 |
32 | FRK | 1.68570570 |
33 | PINK1 | 1.67547252 |
34 | TAF1 | 1.61955538 |
35 | LATS1 | 1.60319366 |
36 | NUAK1 | 1.54849186 |
37 | BRSK2 | 1.51686912 |
38 | PLK1 | 1.47994253 |
39 | MAP2K4 | 1.44498167 |
40 | CAMK1D | 1.43228339 |
41 | TIE1 | 1.41471235 |
42 | PIM2 | 1.41451362 |
43 | LMTK2 | 1.40485335 |
44 | STK38L | 1.39605005 |
45 | TRIM28 | 1.36836350 |
46 | STK39 | 1.35841987 |
47 | PTK6 | 1.34870702 |
48 | EEF2K | 1.33280196 |
49 | ERBB4 | 1.32978768 |
50 | NME1 | 1.32400862 |
51 | STK16 | 1.31495663 |
52 | PRKAA2 | 1.25639205 |
53 | PHKG2 | 1.22106426 |
54 | PHKG1 | 1.22106426 |
55 | ATR | 1.21857488 |
56 | BMPR1B | 1.21153786 |
57 | CSNK1G3 | 1.20435709 |
58 | MAPK11 | 1.17570658 |
59 | CHEK2 | 1.16388801 |
60 | NME2 | 1.16352618 |
61 | MKNK1 | 1.15617261 |
62 | RIPK1 | 1.14399125 |
63 | CSNK1G1 | 1.12924153 |
64 | MAP3K7 | 1.12246870 |
65 | CDK7 | 1.06700075 |
66 | MET | 1.04040483 |
67 | MKNK2 | 1.03920607 |
68 | FGFR2 | 1.03792855 |
69 | FLT3 | 1.03775129 |
70 | RPS6KB2 | 1.03192018 |
71 | AURKA | 1.02233629 |
72 | PIK3CG | 1.02029571 |
73 | CAMK1G | 1.01830576 |
74 | BRSK1 | 1.01547071 |
75 | PRKAA1 | 0.99707275 |
76 | MAP3K3 | 0.98052829 |
77 | TTN | 0.96420059 |
78 | NEK9 | 0.95891791 |
79 | AURKB | 0.95820953 |
80 | DAPK2 | 0.94609265 |
81 | MAP4K2 | 0.94571496 |
82 | MAP3K2 | 0.93949374 |
83 | EPHB1 | 0.93773821 |
84 | CSNK1G2 | 0.93153660 |
85 | CSNK1A1L | 0.92028174 |
86 | MYLK | 0.90018407 |
87 | PDPK1 | 0.87806051 |
88 | ACVR1B | 0.85808521 |
89 | EIF2AK2 | 0.83948342 |
90 | CCNB1 | 0.83030465 |
91 | PIK3CA | 0.82482077 |
92 | RAF1 | 0.82450667 |
93 | OBSCN | 0.82110555 |
94 | ATM | 0.81484252 |
95 | SGK223 | 0.80939947 |
96 | SGK494 | 0.80939947 |
97 | NEK1 | 0.80909307 |
98 | MAPK15 | 0.78790555 |
99 | CHEK1 | 0.77762959 |
100 | JAK2 | 0.77236026 |
101 | MUSK | 0.76303955 |
102 | ICK | 0.75023226 |
103 | SGK3 | 0.74405023 |
104 | EPHB2 | 0.74160921 |
105 | ABL2 | 0.73943719 |
106 | MAPK12 | 0.72781824 |
107 | GSK3A | 0.71388626 |
108 | NEK2 | 0.71302289 |
109 | BRAF | 0.70702918 |
110 | PRKACG | 0.69075830 |
111 | MAP2K1 | 0.68794163 |
112 | PDGFRA | 0.67933883 |
113 | CSNK2A2 | 0.67394481 |
114 | KSR2 | 0.66107476 |
115 | PRKCI | 0.65150347 |
116 | MAP2K3 | 0.65021565 |
117 | CSNK1E | 0.63394008 |
118 | PRKD3 | 0.63331880 |
119 | MAPKAPK3 | 0.60985561 |
120 | PLK2 | 0.60719679 |
121 | PNCK | 0.60715906 |
122 | CSNK2A1 | 0.60611201 |
123 | RET | 0.60491428 |
124 | TGFBR2 | 0.60265970 |
125 | PAK3 | 0.60258108 |
126 | CDK1 | 0.59659131 |
127 | BCR | 0.58305941 |
128 | PRKCZ | 0.58238419 |
129 | CAMK2G | 0.57995606 |
130 | DYRK2 | 0.57270286 |
131 | PDK1 | 0.56332448 |
132 | FER | 0.56170632 |
133 | GRK1 | 0.55745031 |
134 | MAP3K10 | 0.55641240 |
135 | ERBB2 | 0.55165757 |
136 | PRKD1 | 0.54843701 |
137 | STK4 | 0.54836422 |
138 | DAPK1 | 0.54205221 |
139 | MAP3K8 | 0.53847700 |
140 | CDK2 | 0.53684496 |
141 | MAP2K2 | 0.53678573 |
142 | PRKCH | 0.53292574 |
143 | SMG1 | 0.53000334 |
144 | MAP3K11 | 0.52986693 |
145 | PTK2 | 0.52478506 |
146 | MAPKAPK5 | 0.51556704 |
147 | STK38 | 0.49748648 |
148 | AKT2 | 0.49318684 |
149 | PRKDC | 0.48966594 |
150 | RPS6KA5 | 0.48232677 |
151 | STK3 | 0.48011902 |
152 | MAP3K1 | 0.46697650 |
153 | DYRK3 | 0.46518812 |
154 | CDK8 | 0.45952683 |
155 | ARAF | 0.44676188 |
156 | DYRK1B | 0.44075371 |
157 | TNIK | 0.43818075 |
158 | SGK2 | 0.42445666 |
159 | MAPK4 | 0.41003534 |
160 | WNK1 | 0.39398097 |
161 | PASK | 0.39056317 |
162 | CASK | 0.38890169 |
163 | ALK | 0.38821977 |
164 | MTOR | 0.38810570 |
165 | MAP3K12 | 0.38636433 |
166 | IRAK3 | 0.37565538 |
167 | ERBB3 | 0.37429825 |
168 | JAK1 | 0.37096019 |
169 | DAPK3 | 0.35892807 |
170 | CSNK1A1 | 0.35866994 |
171 | RPS6KB1 | 0.35738115 |
172 | GRK6 | 0.35709000 |
173 | AKT3 | 0.35645782 |
174 | KDR | 0.34874420 |
175 | FGFR3 | 0.33519753 |
176 | PKN1 | 0.33070877 |
177 | LATS2 | 0.32131432 |
178 | NTRK1 | 0.31568283 |
179 | MAP2K6 | 0.29941982 |
180 | TYK2 | 0.29665972 |
181 | EPHA3 | 0.27091604 |
182 | PRKACA | 0.26839234 |
183 | IGF1R | 0.26518149 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.50807593 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.15785810 |
3 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.07514394 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.00858378 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93563943 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.89042173 |
7 | * Propanoate metabolism_Homo sapiens_hsa00640 | 2.85095620 |
8 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.81277927 |
9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.59810232 |
10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.56537361 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.53932940 |
12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.43826832 |
13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.41472542 |
14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.37957425 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.22460065 |
16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.17030725 |
17 | DNA replication_Homo sapiens_hsa03030 | 2.14373762 |
18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.12118000 |
19 | Peroxisome_Homo sapiens_hsa04146 | 2.10839173 |
20 | Proteasome_Homo sapiens_hsa03050 | 2.06587651 |
21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.03714799 |
22 | Mismatch repair_Homo sapiens_hsa03430 | 2.03119757 |
23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.00896349 |
24 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.99991347 |
25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.89501832 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86888115 |
27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83589009 |
28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.70525672 |
29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65464371 |
30 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.56156730 |
31 | Base excision repair_Homo sapiens_hsa03410 | 1.55583374 |
32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54528764 |
33 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.54165628 |
34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.53574694 |
35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53298385 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.48531551 |
37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.47898636 |
38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.45379252 |
39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.44372548 |
40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41740750 |
41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.39524592 |
42 | RNA polymerase_Homo sapiens_hsa03020 | 1.39191285 |
43 | Homologous recombination_Homo sapiens_hsa03440 | 1.38728733 |
44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38542205 |
45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36322589 |
46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35042570 |
47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33467371 |
48 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.33261294 |
49 | Ribosome_Homo sapiens_hsa03010 | 1.32762310 |
50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28689563 |
51 | RNA transport_Homo sapiens_hsa03013 | 1.27222753 |
52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26093420 |
53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24845207 |
54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21560913 |
55 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19867343 |
56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18716255 |
57 | Protein export_Homo sapiens_hsa03060 | 1.18356688 |
58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17654017 |
59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12394696 |
60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12120010 |
61 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09050881 |
62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08414894 |
63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06704761 |
64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.06209719 |
65 | Huntingtons disease_Homo sapiens_hsa05016 | 1.05085088 |
66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03343481 |
67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00867047 |
68 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.00783302 |
69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99914594 |
70 | Basal transcription factors_Homo sapiens_hsa03022 | 0.99022686 |
71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.98879503 |
72 | ABC transporters_Homo sapiens_hsa02010 | 0.95756308 |
73 | Spliceosome_Homo sapiens_hsa03040 | 0.95357526 |
74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89636190 |
75 | Cell cycle_Homo sapiens_hsa04110 | 0.87362965 |
76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86915705 |
77 | RNA degradation_Homo sapiens_hsa03018 | 0.86460649 |
78 | Lysine degradation_Homo sapiens_hsa00310 | 0.86218768 |
79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83674675 |
80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81719791 |
81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79669548 |
82 | Purine metabolism_Homo sapiens_hsa00230 | 0.74141949 |
83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70804562 |
84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70023328 |
85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61212963 |
86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61166008 |
87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55815811 |
88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52107169 |
89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51543868 |
90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51376718 |
91 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50394028 |
92 | Insulin resistance_Homo sapiens_hsa04931 | 0.47311936 |
93 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.46598551 |
94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46586808 |
95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40100958 |
96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.37066296 |
97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36366425 |
98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35269544 |
99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33325199 |
100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31741074 |
101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30226428 |
102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26911150 |
103 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.23283129 |
104 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.21178016 |
105 | Prion diseases_Homo sapiens_hsa05020 | 0.20547948 |
106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17835233 |
107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.17215103 |
108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16615855 |
109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16296623 |
110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.14535840 |
111 | Parkinsons disease_Homo sapiens_hsa05012 | 0.12670885 |
112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.09287617 |
113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08384807 |
114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05458120 |
115 | Alzheimers disease_Homo sapiens_hsa05010 | 0.04954805 |
116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.03204725 |
117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.00909991 |
118 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0754492 |
119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0675123 |
120 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0548796 |
121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0404508 |
122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0364937 |
123 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0184840 |
124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0181067 |
125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0180790 |
126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0091699 |
127 | Mineral absorption_Homo sapiens_hsa04978 | -0.0090633 |